 | • レポートコード：MRC23Q35910 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のコルチコステロイド反応性疾患市場について調査・分析し、世界のコルチコステロイド反応性疾患市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（注射、経口）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Avik Pharmaceuticals Ltd.、Cipla Limited、Bristol-Myers Squibb Co.、Mylan Laboratories Limited、Teva Pharmaceutical Industries、Pfizer Inc.などが含まれています。世界のコルチコステロイド反応性疾患市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、コルチコステロイド反応性疾患市場規模を推定する際に考慮しました。本レポートは、コルチコステロイド反応性疾患の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、コルチコステロイド反応性疾患に関するビジネス上の意思決定に役立てることを目的としています。 ・コルチコステロイド反応性疾患市場の概要 - コルチコステロイド反応性疾患のタイプ別セグメント - 世界のコルチコステロイド反応性疾患市場規模：タイプ別分析（注射、経口） - コルチコステロイド反応性疾患の用途別セグメント - 世界のコルチコステロイド反応性疾患市場規模：用途別分析（病院、薬局、その他） - 世界のコルチコステロイド反応性疾患市場規模予測（2018年-2029年） ・コルチコステロイド反応性疾患市場の成長トレンド - コルチコステロイド反応性疾患の地域別市場規模（2018年-2029年） - コルチコステロイド反応性疾患市場ダイナミクス - コルチコステロイド反応性疾患の業界動向 - コルチコステロイド反応性疾患市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：注射、経口 - 世界のコルチコステロイド反応性疾患のタイプ別市場規模（2018年-2023年） - 世界のコルチコステロイド反応性疾患のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、薬局、その他 - 世界のコルチコステロイド反応性疾患の用途別市場規模（2018年-2023年） - 世界のコルチコステロイド反応性疾患の用途別市場規模（2024年-2029年） ・コルチコステロイド反応性疾患の地域別市場規模 - 北米のコルチコステロイド反応性疾患市場規模（2018年-2029年） - アメリカのコルチコステロイド反応性疾患市場規模（2018年-2029年） - ヨーロッパのコルチコステロイド反応性疾患市場規模（2018年-2029年） - アジア太平洋のコルチコステロイド反応性疾患市場規模（2018年-2029年） - 中国のコルチコステロイド反応性疾患市場規模（2018年-2029年） - 日本のコルチコステロイド反応性疾患市場規模（2018年-2029年） - 韓国のコルチコステロイド反応性疾患市場規模（2018年-2029年） - インドのコルチコステロイド反応性疾患市場規模（2018年-2029年） - オーストラリアのコルチコステロイド反応性疾患市場規模（2018年-2029年） - 中南米のコルチコステロイド反応性疾患市場規模（2018年-2029年） - 中東・アフリカのコルチコステロイド反応性疾患市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Avik Pharmaceuticals Ltd.、Cipla Limited、Bristol-Myers Squibb Co.、Mylan Laboratories Limited、Teva Pharmaceutical Industries、Pfizer Inc. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Corticosteroid-Responsive Disorders market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Corticosteroid-Responsive Disorders is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Corticosteroid-Responsive Disorders is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Corticosteroid-Responsive Disorders in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Corticosteroid-Responsive Disorders include Avik Pharmaceuticals Ltd., Cipla Limited, Bristol-Myers Squibb Co., Mylan Laboratories Limited, Teva Pharmaceutical Industries and Pfizer Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Corticosteroid-Responsive Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid-Responsive Disorders.
The Corticosteroid-Responsive Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Corticosteroid-Responsive Disorders market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Corticosteroid-Responsive Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Avik Pharmaceuticals Ltd.
Cipla Limited
Bristol-Myers Squibb Co.
Mylan Laboratories Limited
Teva Pharmaceutical Industries
Pfizer Inc.
Segment by Type
Injection
Oral
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Corticosteroid-Responsive Disorders companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Corticosteroid-Responsive Disorders Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Corticosteroid-Responsive Disorders Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Corticosteroid-Responsive Disorders Market Perspective (2018-2029)
2.2 Corticosteroid-Responsive Disorders Growth Trends by Region
2.2.1 Global Corticosteroid-Responsive Disorders Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Corticosteroid-Responsive Disorders Historic Market Size by Region (2018-2023)
2.2.3 Corticosteroid-Responsive Disorders Forecasted Market Size by Region (2024-2029)
2.3 Corticosteroid-Responsive Disorders Market Dynamics
2.3.1 Corticosteroid-Responsive Disorders Industry Trends
2.3.2 Corticosteroid-Responsive Disorders Market Drivers
2.3.3 Corticosteroid-Responsive Disorders Market Challenges
2.3.4 Corticosteroid-Responsive Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Corticosteroid-Responsive Disorders Players by Revenue
3.1.1 Global Top Corticosteroid-Responsive Disorders Players by Revenue (2018-2023)
3.1.2 Global Corticosteroid-Responsive Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Corticosteroid-Responsive Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Corticosteroid-Responsive Disorders Revenue
3.4 Global Corticosteroid-Responsive Disorders Market Concentration Ratio
3.4.1 Global Corticosteroid-Responsive Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Corticosteroid-Responsive Disorders Revenue in 2022
3.5 Corticosteroid-Responsive Disorders Key Players Head office and Area Served
3.6 Key Players Corticosteroid-Responsive Disorders Product Solution and Service
3.7 Date of Enter into Corticosteroid-Responsive Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Corticosteroid-Responsive Disorders Breakdown Data by Type
4.1 Global Corticosteroid-Responsive Disorders Historic Market Size by Type (2018-2023)
4.2 Global Corticosteroid-Responsive Disorders Forecasted Market Size by Type (2024-2029)
5 Corticosteroid-Responsive Disorders Breakdown Data by Application
5.1 Global Corticosteroid-Responsive Disorders Historic Market Size by Application (2018-2023)
5.2 Global Corticosteroid-Responsive Disorders Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Corticosteroid-Responsive Disorders Market Size (2018-2029)
6.2 North America Corticosteroid-Responsive Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Corticosteroid-Responsive Disorders Market Size by Country (2018-2023)
6.4 North America Corticosteroid-Responsive Disorders Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Corticosteroid-Responsive Disorders Market Size (2018-2029)
7.2 Europe Corticosteroid-Responsive Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Corticosteroid-Responsive Disorders Market Size by Country (2018-2023)
7.4 Europe Corticosteroid-Responsive Disorders Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Corticosteroid-Responsive Disorders Market Size (2018-2029)
8.2 Asia-Pacific Corticosteroid-Responsive Disorders Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Corticosteroid-Responsive Disorders Market Size by Region (2018-2023)
8.4 Asia-Pacific Corticosteroid-Responsive Disorders Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Corticosteroid-Responsive Disorders Market Size (2018-2029)
9.2 Latin America Corticosteroid-Responsive Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Corticosteroid-Responsive Disorders Market Size by Country (2018-2023)
9.4 Latin America Corticosteroid-Responsive Disorders Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Corticosteroid-Responsive Disorders Market Size (2018-2029)
10.2 Middle East & Africa Corticosteroid-Responsive Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Corticosteroid-Responsive Disorders Market Size by Country (2018-2023)
10.4 Middle East & Africa Corticosteroid-Responsive Disorders Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Avik Pharmaceuticals Ltd.
11.1.1 Avik Pharmaceuticals Ltd. Company Detail
11.1.2 Avik Pharmaceuticals Ltd. Business Overview
11.1.3 Avik Pharmaceuticals Ltd. Corticosteroid-Responsive Disorders Introduction
11.1.4 Avik Pharmaceuticals Ltd. Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.1.5 Avik Pharmaceuticals Ltd. Recent Development
11.2 Cipla Limited
11.2.1 Cipla Limited Company Detail
11.2.2 Cipla Limited Business Overview
11.2.3 Cipla Limited Corticosteroid-Responsive Disorders Introduction
11.2.4 Cipla Limited Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.2.5 Cipla Limited Recent Development
11.3 Bristol-Myers Squibb Co.
11.3.1 Bristol-Myers Squibb Co. Company Detail
11.3.2 Bristol-Myers Squibb Co. Business Overview
11.3.3 Bristol-Myers Squibb Co. Corticosteroid-Responsive Disorders Introduction
11.3.4 Bristol-Myers Squibb Co. Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.3.5 Bristol-Myers Squibb Co. Recent Development
11.4 Mylan Laboratories Limited
11.4.1 Mylan Laboratories Limited Company Detail
11.4.2 Mylan Laboratories Limited Business Overview
11.4.3 Mylan Laboratories Limited Corticosteroid-Responsive Disorders Introduction
11.4.4 Mylan Laboratories Limited Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.4.5 Mylan Laboratories Limited Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Corticosteroid-Responsive Disorders Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Detail
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Corticosteroid-Responsive Disorders Introduction
11.6.4 Pfizer Inc. Revenue in Corticosteroid-Responsive Disorders Business (2018-2023)
11.6.5 Pfizer Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details